SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-017012
Filing Date
2024-06-14
Accepted
2024-06-14 18:05:11
Documents
1
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 form4-06142024_060608.html 4  
1 form4-06142024_060608.xml 4 4104
  Complete submission text file 0001415889-24-017012.txt   5836
Mailing Address 10 FINDERNE AVENUE BRIDGEWATER NJ 08807
Business Address
Pellizzari Christine A (Reporting) CIK: 0001127430 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35890 | Film No.: 241046321

Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)